Product Information
POTASSIUM CL ER 8 MEQ TABLET is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.1379 per EA under NDC 70436000101. Its NADAC has been published 333 times since Jan 2, 2019.
FDA first approved this application on Jun 22, 2018. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436000101
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209314FDA Approved
6/22/2018
TE Code
AB2
On Market Since
11/15/2018
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CL ER 8 MEQ TABLET has been published 333 times since Jan 2, 2019, and over the history we have for it it has declined 33.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1379 per EA |
|---|---|
| All-time high | $0.2399 (Jan 15, 2020) |
| All-time low | $0.1059 (Apr 17, 2024) |
| Median price | $0.1745 |
| Average price | $0.1726 |
| Largest weekly change | -39.3% (Apr 17, 2024) |
| Weeks tracked | 333 |
| Tracking since | Jan 2, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+3.8%
5Y
-21.4%
All
-33.6%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of POTASSIUM CL ER 8 MEQ TABLET?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 8 MEQ TABLET, manufactured by Slate Run Pharmaceuticals LLC, is $0.1379 per EA (NDC 70436000101), effective May 14, 2025.
How has the price of POTASSIUM CL ER 8 MEQ TABLET changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL ER 8 MEQ TABLET has declined 33.6%. It has been tracked across 333 weekly CMS publications since Jan 2, 2019.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 8 MEQ TABLET?
Since Jan 2, 2019, the NADAC for POTASSIUM CL ER 8 MEQ TABLET has ranged from a low of $0.1059 (Apr 17, 2024) to a high of $0.2399 (Jan 15, 2020), with a median of $0.1745 per EA.
Are there cheaper alternatives to POTASSIUM CL ER 8 MEQ TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 8 MEQ TABLET, is $0.1020 per EA — about 26% below POTASSIUM CL ER 8 MEQ TABLET.
Who manufactures POTASSIUM CL ER 8 MEQ TABLET?
POTASSIUM CL ER 8 MEQ TABLET (NDC 70436000101) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.